Bio-Rad Laboratories, Inc. (NYSE:BIO.B – Get Free Report)’s share price gapped up before the market opened on Wednesday. The stock had previously closed at $337.00, but opened at $364.21. Bio-Rad Laboratories shares last traded at $364.15, with a volume of 227 shares trading hands.
Bio-Rad Laboratories Price Performance
The company has a market capitalization of $9.74 billion, a P/E ratio of 44.14 and a beta of 0.96. The company has a current ratio of 3.14, a quick ratio of 2.33 and a debt-to-equity ratio of 0.11. The business’s fifty day moving average price is $359.35 and its 200-day moving average price is $315.10.
Bio-Rad Laboratories Company Profile
Bio-Rad Laboratories, Inc develops, manufactures and sells products and services used in life science research and clinical diagnostics. The company serves academic and government laboratories, pharmaceutical and biotechnology companies, hospitals, clinical laboratories and other healthcare organizations.
Bio-Rad’s Life Science segment provides instruments, reagents, software and consumables for applications including gene expression analysis, polymerase chain reaction, digital PCR, protein research, cell biology, chromatography, electrophoresis and laboratory quality control.
Recommended Stories
- Five stocks we like better than Bio-Rad Laboratories
- Tesla Wants to Make Its Own Chips—What Could Go Wrong?
- IREN Limited’s AI Pivot Gains Traction—But Can Its Data Centers Deliver?
- PBF Energy’s Stunning Rally Faces a Critical Test
- Citi Stock Falls Despite Earnings Beat: What Investors Need to Know
Receive News & Ratings for Bio-Rad Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bio-Rad Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.
